1. Home
  2. LUNG vs ALOT Comparison

LUNG vs ALOT Comparison

Compare LUNG & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ALOT
  • Stock Information
  • Founded
  • LUNG 1995
  • ALOT 1969
  • Country
  • LUNG United States
  • ALOT United States
  • Employees
  • LUNG N/A
  • ALOT N/A
  • Industry
  • LUNG Industrial Specialties
  • ALOT Computer peripheral equipment
  • Sector
  • LUNG Health Care
  • ALOT Technology
  • Exchange
  • LUNG Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • LUNG 65.6M
  • ALOT 69.2M
  • IPO Year
  • LUNG 2020
  • ALOT N/A
  • Fundamental
  • Price
  • LUNG $1.76
  • ALOT $10.46
  • Analyst Decision
  • LUNG Buy
  • ALOT
  • Analyst Count
  • LUNG 7
  • ALOT 0
  • Target Price
  • LUNG $7.66
  • ALOT N/A
  • AVG Volume (30 Days)
  • LUNG 915.9K
  • ALOT 6.5K
  • Earning Date
  • LUNG 07-30-2025
  • ALOT 09-15-2025
  • Dividend Yield
  • LUNG N/A
  • ALOT N/A
  • EPS Growth
  • LUNG N/A
  • ALOT N/A
  • EPS
  • LUNG N/A
  • ALOT N/A
  • Revenue
  • LUNG $90,549,000.00
  • ALOT $156,030,000.00
  • Revenue This Year
  • LUNG $10.30
  • ALOT N/A
  • Revenue Next Year
  • LUNG $14.72
  • ALOT N/A
  • P/E Ratio
  • LUNG N/A
  • ALOT N/A
  • Revenue Growth
  • LUNG 18.24
  • ALOT 7.14
  • 52 Week Low
  • LUNG $1.47
  • ALOT $7.53
  • 52 Week High
  • LUNG $9.37
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 42.85
  • ALOT 48.73
  • Support Level
  • LUNG $1.62
  • ALOT $10.77
  • Resistance Level
  • LUNG $1.83
  • ALOT $11.17
  • Average True Range (ATR)
  • LUNG 0.12
  • ALOT 0.42
  • MACD
  • LUNG 0.07
  • ALOT -0.08
  • Stochastic Oscillator
  • LUNG 69.05
  • ALOT 24.59

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: